KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Cash from Financing Activities (2016 - 2026)

Palvella Therapeutics has reported Cash from Financing Activities over the past 10 years, most recently at $93000.0 for Q4 2022.

  • Quarterly Cash from Financing Activities fell 98.1% to $93000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2022, down 87.8% year-over-year, with the annual reading at -$660000.0 for FY2025, 100.76% down from the prior year.
  • Cash from Financing Activities was $93000.0 for Q4 2022 at Palvella Therapeutics, down from $282000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $48.2 million in Q1 2018 and troughed at $7000.0 in Q4 2018.
  • The 5-year median for Cash from Financing Activities is $349000.0 (2020), against an average of $8.7 million.
  • Year-over-year, Cash from Financing Activities surged 452257.14% in 2019 and then tumbled 99.76% in 2020.
  • A 5-year view of Cash from Financing Activities shows it stood at $7000.0 in 2018, then surged by 452257.14% to $31.7 million in 2019, then tumbled by 99.76% to $75000.0 in 2020, then surged by 6434.67% to $4.9 million in 2021, then tumbled by 98.1% to $93000.0 in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Cash from Financing Activities are $93000.0 (Q4 2022), $282000.0 (Q3 2022), and $281000.0 (Q2 2022).